China
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 7.15 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
2 |
USD 6.83 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
3 |
USD 5.62 B
|
Dec. 31, 2023 | USD 0.52 | 6.79% |
|
China |
|
4 |
USD 4.36 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
5 |
USD 3.44 B
|
Dec. 31, 2023 | USD 0.56 | 0.44% |
|
China |
|
6 |
USD 3.26 B
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
7 |
USD 2.77 B
|
Dec. 31, 2023 | USD 1.71 | 1.65% |
|
China |
|
8 |
USD 2.72 B
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
9 |
USD 2.33 B
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
10 |
USD 2.01 B
|
Dec. 31, 2023 | USD 3.45 | 3.36% |
|
China |
|
11 |
USD 2.00 B
|
Dec. 31, 2023 | USD 2.27 | 3.13% |
|
China |
|
12 |
USD 1.83 B
|
Dec. 31, 2023 | USD 5.92 | 1.98% |
|
China |
|
13 |
USD 1.77 B
|
Dec. 31, 2023 | USD 4.53 | 2.64% |
|
China |
|
14 |
USD 1.75 B
|
Dec. 31, 2023 | USD 12.91 | 2.15% |
|
China |
|
15 |
USD 1.71 B
|
Dec. 31, 2023 | USD 0.67 | 1.67% |
|
China |
|
16 |
USD 1.67 B
|
Dec. 31, 2023 | USD 3.65 | 3.06% |
|
China |
|
17 |
USD 1.58 B
|
Dec. 31, 2023 | USD 2.91 | 1.87% |
|
China |
|
18 |
USD 1.57 B
|
Dec. 31, 2023 | USD 3.86 | 1.55% |
|
China |
|
19 |
USD 1.46 B
|
Dec. 31, 2023 | USD 7.83 | 2.23% |
|
China |
|
20 |
USD 1.46 B
|
Dec. 31, 2023 | USD 1.47 | 0.94% |
|
China |
|
21 |
USD 1.46 B
|
Dec. 31, 2023 | USD 1.73 | 3.02% |
|
China |
|
22 |
USD 1.28 B
|
Dec. 31, 2023 | USD 2.14 | 2.31% |
|
China |
|
23 |
USD 1.27 B
|
Dec. 31, 2023 | USD 3.66 | 2.21% |
|
China |
|
24 |
USD 1.26 B
|
Dec. 31, 2023 | USD 2.09 | 1.26% |
|
China |
|
25 |
USD 1.24 B
|
Dec. 31, 2023 | USD 1.93 | 2.10% |
|
China |
|
26 |
USD 1.21 B
|
Dec. 31, 2023 | USD 3.33 | 0.92% |
|
China |
|
27 |
USD 1.19 B
|
Dec. 31, 2023 | USD 5.16 | 2.25% |
|
China |
|
28 |
USD 1.11 B
|
Dec. 31, 2023 | USD 3.86 | 1.95% |
|
China |
|
29 |
USD 1.08 B
|
Dec. 31, 2023 | USD 3.31 | 1.16% |
|
China |
|
30 |
USD 1.07 B
|
Dec. 31, 2023 | USD 3.00 | 0.74% |
|
China |
|
31 |
USD 1.03 B
|
Dec. 31, 2023 | USD 2.19 | 4.03% |
|
China |
|
32 |
USD 961.71 M
|
Dec. 31, 2023 | USD 2.26 | 4.12% |
|
China |
|
33 |
USD 935.67 M
|
Dec. 31, 2023 | USD 0.54 | 1.42% |
|
China |
|
34 |
USD 935.47 M
|
Dec. 31, 2023 | USD 0.74 | 1.21% |
|
China |
|
35 |
USD 912.74 M
|
Dec. 31, 2023 | USD 1.59 | 3.28% |
|
China |
|
36 |
USD 884.21 M
|
Dec. 31, 2023 | USD 0.70 | 2.41% |
|
China |
|
37 |
USD 879.94 M
|
Dec. 31, 2023 | USD 0.67 | 0.94% |
|
China |
|
38 |
USD 832.49 M
|
Dec. 31, 2023 | USD 2.18 | 1.66% |
|
China |
|
39 |
USD 815.35 M
|
Dec. 31, 2023 | USD 1.91 | 2.05% |
|
China |
|
40 |
USD 790.90 M
|
Dec. 31, 2023 | USD 2.64 | 2.39% |
|
China |
|
41 |
USD 781.86 M
|
Dec. 31, 2023 | USD 1.67 | 2.01% |
|
China |
|
42 |
USD 768.78 M
|
Dec. 31, 2023 | USD 1.32 | 0.63% |
|
China |
|
43 |
USD 707.12 M
|
Dec. 31, 2023 | USD 2.17 | 1.34% |
|
China |
|
44 |
USD 703.98 M
|
Dec. 31, 2023 | USD 1.49 | 3.42% |
|
China |
|
45 |
USD 702.02 M
|
Dec. 31, 2023 | USD 0.84 | 0.74% |
|
China |
|
46 |
USD 666.09 M
|
Dec. 31, 2023 | USD 0.25 | 2.80% |
|
China |
|
47 |
USD 662.45 M
|
Dec. 31, 2023 | USD 28.52 | 2.04% |
|
China |
|
48 |
USD 656.53 M
|
Dec. 31, 2023 | USD 0.61 | 2.08% |
|
China |
|
49 |
USD 643.95 M
|
Dec. 31, 2023 | USD 0.61 | 1.47% |
|
China |
|
50 |
USD 633.57 M
|
Dec. 31, 2023 | USD 9.47 | 1.45% |
|
China |
The Health Care company in China with the highest Gross Profit is Fosun International Limited (HKSE: 0656.HK) at USD 7.15 B.
The Health Care company in China with the lowest Gross Profit is Fujian Aonong Biological Technology Group Incorporation Limited (Shanghai Stock Exchange: 603363.SS) at USD -184.41 M.
The top 10 Health Care companies in China by Gross Profit are Fosun International Limited, Sinopharm Group Co. Ltd., Hubei Biocause Pharmaceutical Co., Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, CSPC Pharmaceutical Group Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., WuXi AppTec Co., Ltd. and Chongqing Zhifei Biological Products Co., Ltd..
The bottom 10 Health Care companies in China by Gross Profit are Fujian Aonong Biological Technology Group Incorporation Limited, CanSino Biologics Inc., AIM Vaccine Co., Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Lifecome Biochemistry Co.,Ltd., Concord Medical Services Holdings Limited, Jiangsu Lanfeng Bio-chemical Co.,Ltd, Zhongzhu Healthcare Holding Co.,Ltd, Shanghai Bio-heart Biological Technology Co., Ltd. and Shanghai ZJ Bio-Tech Co., Ltd..